Glenmark Life Science, a high-value active pharmaceutical ingredients (API) manufacturer, opened its IPO offer on July 27, 2021. On the first day of the subscription period, which will continue till July 29, 2021, the offer received a 2.78x subscription. Investors in the retail quota subscribed 5.16 times the quota available to them. Non-institutional investors too …